Published in Surgery on December 30, 2009
More than just tumor destruction: immunomodulation by thermal ablation of cancer. Clin Dev Immunol (2011) 1.56
Recent Advances in Tumor Ablation for Hepatocellular Carcinoma. Liver Cancer (2015) 1.08
Percutaneous tumor ablation tools: microwave, radiofrequency, or cryoablation--what should you use and why? Radiographics (2014) 1.04
Radiofrequency ablation of liver tumors: Actual limitations and potential solutions in the future. World J Hepatol (2011) 0.95
Induction of rapid, reproducible hepatic ablations using next-generation, high frequency irreversible electroporation (H-FIRE) in vivo. HPB (Oxford) (2016) 0.79
The ongoing history of thermal therapy for cancer. Surg Oncol Clin N Am (2010) 0.79
Treatment of neuroendocrine tumor liver metastases. Int J Hepatol (2012) 0.76
Incidence of hypercoagulable events after image-guided percutaneous cryoablation of renal tumors: a single-center experience. J Vasc Interv Radiol (2014) 0.75
Thermal Ablative Therapies and Immune Checkpoint Modulation: Can Locoregional Approaches Effect a Systemic Response? Gastroenterol Res Pract (2016) 0.75
Clinical outcome, proteome kinetics and angiogenic factors in serum after thermoablation of colorectal liver metastases. BMC Cancer (2013) 0.75
Preoperative biliary drainage for cancer of the head of the pancreas. N Engl J Med (2010) 10.21
Reversal of rivaroxaban and dabigatran by prothrombin complex concentrate: a randomized, placebo-controlled, crossover study in healthy subjects. Circulation (2011) 6.47
Self-monitoring of oral anticoagulation: systematic review and meta-analysis of individual patient data. Lancet (2011) 4.78
Prevention and treatment of major blood loss. N Engl J Med (2007) 4.72
Prospective validation of the International Society of Thrombosis and Haemostasis scoring system for disseminated intravascular coagulation. Crit Care Med (2004) 3.89
Acute coagulopathy of trauma: hypoperfusion induces systemic anticoagulation and hyperfibrinolysis. J Trauma (2008) 3.40
Standards of reporting for MRI-targeted biopsy studies (START) of the prostate: recommendations from an International Working Group. Eur Urol (2013) 3.34
Fibrin sealant for prevention of resection surface-related complications after liver resection: a randomized controlled trial. Ann Surg (2012) 3.28
Effect of recombinant activated factor VII on perioperative blood loss in patients undergoing retropubic prostatectomy: a double-blind placebo-controlled randomised trial. Lancet (2003) 2.86
2010 International consensus algorithm for the diagnosis, therapy and management of hereditary angioedema. Allergy Asthma Clin Immunol (2010) 2.75
The optimal intensity of vitamin K antagonists in patients with mechanical heart valves: a meta-analysis. J Am Coll Cardiol (2003) 2.71
A randomized, double-blind, placebo-controlled, Phase 2b study to evaluate the safety and efficacy of recombinant human soluble thrombomodulin, ART-123, in patients with sepsis and suspected disseminated intravascular coagulation. Crit Care Med (2013) 2.68
Dose-finding and pharmacokinetic study of cisplatin, gemcitabine, and SU5416 in patients with solid tumors. J Clin Oncol (2002) 2.55
Activation of inflammation and coagulation after infusion of C-reactive protein in humans. Circ Res (2005) 2.46
Inflammation, endothelium, and coagulation in sepsis. J Leukoc Biol (2007) 2.46
Liver adenomatosis: re-evaluation of aetiology and management. Liver Int (2008) 2.30
Hospital volume and mortality after pancreatic resection: a systematic review and an evaluation of intervention in the Netherlands. Ann Surg (2005) 2.21
Mechanical ventilation with lower tidal volumes and positive end-expiratory pressure prevents alveolar coagulation in patients without lung injury. Anesthesiology (2006) 2.19
Management of liver hemangiomas according to size and symptoms. J Gastroenterol Hepatol (2007) 2.16
Antecolic versus retrocolic route of the gastroenteric anastomosis after pancreatoduodenectomy: a randomized controlled trial. Ann Surg (2014) 2.15
Inhibition of the intrinsic coagulation pathway factor XI by antisense oligonucleotides: a novel antithrombotic strategy with lowered bleeding risk. Blood (2010) 2.14
Dynamic evolution of coagulopathy in the first day of severe sepsis: relationship with mortality and organ failure. Crit Care Med (2005) 2.12
Delayed massive hemorrhage after pancreatic and biliary surgery: embolization or surgery? Ann Surg (2005) 2.06
Hyperglycemia enhances coagulation and reduces neutrophil degranulation, whereas hyperinsulinemia inhibits fibrinolysis during human endotoxemia. Blood (2008) 2.03
Imaging of perihilar cholangiocarcinoma. AJR Am J Roentgenol (2015) 2.00
Loss of endothelial glycocalyx during acute hyperglycemia coincides with endothelial dysfunction and coagulation activation in vivo. Diabetes (2006) 1.97
Association between thrombotic microangiopathy and reduced ADAMTS13 activity in malignant hypertension. Hypertension (2008) 1.95
Effects on coagulation and fibrinolysis induced by influenza in mice with a reduced capacity to generate activated protein C and a deficiency in plasminogen activator inhibitor type 1. Circ Res (2006) 1.95
Redarkening of port-wine stains 10 years after pulsed-dye-laser treatment. N Engl J Med (2007) 1.92
Management of adult Jehovah's Witness patients with acute bleeding. Am J Med (2009) 1.89
Thrombolytic therapy for acute superior mesenteric artery occlusion. J Vasc Interv Radiol (2005) 1.87
Gas6 promotes inflammation by enhancing interactions between endothelial cells, platelets, and leukocytes. Blood (2007) 1.86
Local activation of the tissue factor-factor VIIa pathway in patients with pneumonia and the effect of inhibition of this pathway in murine pneumococcal pneumonia. Crit Care Med (2006) 1.82
Assessment of future remnant liver function using hepatobiliary scintigraphy in patients undergoing major liver resection. J Gastrointest Surg (2010) 1.81
Improved outcome of resection of hilar cholangiocarcinoma (Klatskin tumor). Ann Surg Oncol (2006) 1.78
Eradication of Barrett esophagus with early neoplasia by radiofrequency ablation, with or without endoscopic resection. J Gastrointest Surg (2008) 1.73
Supernatant of aged erythrocytes causes lung inflammation and coagulopathy in a "two-hit" in vivo syngeneic transfusion model. Anesthesiology (2010) 1.72
Factors influencing the local failure rate of radiofrequency ablation of colorectal liver metastases. Ann Surg Oncol (2006) 1.72
Preservation of steatotic livers: a comparison between cold storage and machine perfusion preservation. Liver Transpl (2007) 1.71
Therapeutic delay and survival after surgery for cancer of the pancreatic head with or without preoperative biliary drainage. Ann Surg (2010) 1.70
New fundamentals in hemostasis. Physiol Rev (2013) 1.70
Essential pathogenic and metabolic differences in steatosis induced by choline or methione-choline deficient diets in a rat model. J Gastroenterol Hepatol (2007) 1.67
Struggle for implementation of new strategies in intensive care medicine: anticoagulation, insulin, and lower tidal volumes. J Crit Care (2005) 1.66
Primary colorectal cancers and their subsequent hepatic metastases are genetically different: implications for selection of patients for targeted treatment. Clin Cancer Res (2011) 1.64
Results of postoperative radiotherapy for resectable hilar cholangiocarcinoma. World J Surg (2003) 1.62
Serum levels of mannose-binding lectin and the risk of future coronary artery disease in apparently healthy men and women. Arterioscler Thromb Vasc Biol (2006) 1.62
Time course of platelet counts in critically ill patients. Crit Care Med (2002) 1.60
Additional value of contrast enhanced intraoperative ultrasound for colorectal liver metastases. Eur J Radiol (2007) 1.60
Antithrombin inhibits bronchoalveolar activation of coagulation and limits lung injury during Streptococcus pneumoniae pneumonia in rats. Crit Care Med (2008) 1.58
Activation of coagulation and inhibition of fibrinolysis in the human lung on bronchial instillation of lipoteichoic acid and lipopolysaccharide. Crit Care Med (2009) 1.55
Evaluation of a new immortalized human fetal liver cell line (cBAL111) for application in bioartificial liver. J Hepatol (2007) 1.55
Pulmonary activation of coagulation and inhibition of fibrinolysis after burn injuries and inhalation trauma. J Trauma (2011) 1.54
Hepatobiliary function assessed by 99mTc-mebrofenin cholescintigraphy in the evaluation of severity of steatosis in a rat model. Eur J Nucl Med Mol Imaging (2006) 1.50
Steatosis as a risk factor in liver surgery. Ann Surg (2007) 1.48
Salivating for knowledge: potential pharmacological agents in tick saliva. PLoS Med (2008) 1.46
Endoscopic and percutaneous preoperative biliary drainage in patients with suspected hilar cholangiocarcinoma. J Gastrointest Surg (2009) 1.45
Time-course of cytokines during delirium in elderly patients with hip fractures. J Am Geriatr Soc (2008) 1.45
Gastric conduit staple line after esophagectomy: to oversew or not? J Thorac Cardiovasc Surg (2006) 1.44
Dobutamine does not influence inflammatory pathways during human endotoxemia. Crit Care Med (2006) 1.44
Assessment of hepatic steatosis in patients undergoing liver resection: comparison of US, CT, T1-weighted dual-echo MR imaging, and point-resolved 1H MR spectroscopy. Radiology (2010) 1.44
Quantitative electroencephalography in a swine model of cerebral arterial gas embolism. Clin Neurophysiol (2011) 1.44
Fibrin-thrombin coated sealant increases strength of esophagogastric anastomoses in a rat model. J Surg Res (2012) 1.43
Cytokines and acute phase response in delirium. J Psychosom Res (2007) 1.42
(99m)Tc-mebrofenin hepatobiliary scintigraphy with SPECT for the assessment of hepatic function and liver functional volume before partial hepatectomy. J Nucl Med (2010) 1.42
Physiological and biochemical basis of clinical liver function tests: a review. Ann Surg (2013) 1.41
Formation of fibrosis after nonablative and ablative fractional laser therapy. Dermatol Surg (2011) 1.41
Endogenous tissue-type plasminogen activator impairs host defense during severe experimental Gram-negative sepsis (melioidosis)*. Crit Care Med (2012) 1.41
Preoperative assessment of postoperative remnant liver function using hepatobiliary scintigraphy. J Nucl Med (2004) 1.40
Quantitative assessment of hepatic function during liver regeneration in a standardized rat model. J Nucl Med (2011) 1.40
Urokinase receptor is necessary for adequate host defense against pneumococcal pneumonia. J Immunol (2002) 1.39
Geriatric conditions in acutely hospitalized older patients: prevalence and one-year survival and functional decline. PLoS One (2011) 1.39
The anatomy lesson of Dr. Nicolaes Tulp painted by Rembrandt in 1632. ANZ J Surg (2008) 1.38
[Preoperative biliary drainage for pancreatic head tumours: more complications] Ned Tijdschr Geneeskd (2010) 1.38
Factors that predict outcome of intensive care treatment in very elderly patients: a review. Crit Care (2005) 1.37
Tissue factor and coronary artery disease. Cardiovasc Res (2002) 1.37
Complement-mediated ischemia-reperfusion injury: lessons learned from animal and clinical studies. Ann Surg (2009) 1.36
Risk assessment of posthepatectomy liver failure using hepatobiliary scintigraphy and CT volumetry. J Nucl Med (2007) 1.34
Laparoscopic total gastrectomy versus open total gastrectomy for cancer: a systematic review and meta-analysis. Surg Endosc (2012) 1.34
Activated protein C inhibits local coagulation after intrapulmonary delivery of endotoxin in humans. Am J Respir Crit Care Med (2005) 1.33
Bioavailability of subcutaneous low-molecular-weight heparin to patients on vasopressors. Lancet (2002) 1.32
Successful pulmonary administration of activated recombinant factor VII in diffuse alveolar hemorrhage. Crit Care (2006) 1.32
Factor VIII expression in liver disease. Thromb Haemost (2004) 1.31
Transporters involved in the hepatic uptake of (99m)Tc-mebrofenin and indocyanine green. J Hepatol (2010) 1.29
Management of giant liver hemangiomas: an update. Expert Rev Gastroenterol Hepatol (2013) 1.25
Referral pattern and timing of repair are risk factors for complications after reconstructive surgery for bile duct injury. Ann Surg (2007) 1.25
Survival in bile duct injury patients after laparoscopic cholecystectomy: a multidisciplinary approach of gastroenterologists, radiologists, and surgeons. Surgery (2007) 1.25
The effect of a multimodal fast-track programme on outcomes in laparoscopic liver surgery: a multicentre pilot study. HPB (Oxford) (2009) 1.25
Clinical application of bioartificial liver support systems. Ann Surg (2004) 1.24
Induction of tumor growth after preoperative portal vein embolization: is it a real problem? Ann Surg Oncol (2008) 1.24
The effect of inflammation on coagulation and vice versa. Curr Opin Infect Dis (2011) 1.23
Diagnostic value of routine aqueous contrast swallow examination after oesophagectomy for detecting leakage of the cervical oesophagogastric anastomosis. ANZ J Surg (2008) 1.22
Hyperglycemia stimulates coagulation, whereas hyperinsulinemia impairs fibrinolysis in healthy humans. Diabetes (2006) 1.22
Plasminogen activator inhibitor type 1 is protective during severe Gram-negative pneumonia. Blood (2006) 1.21
Vascular endothelial growth factor-mediated induction of manganese superoxide dismutase occurs through redox-dependent regulation of forkhead and IkappaB/NF-kappaB. J Biol Chem (2004) 1.20
Cognitive, functional, and quality-of-life outcomes of patients aged 80 and older who survived at least 1 year after planned or unplanned surgery or medical intensive care treatment. J Am Geriatr Soc (2008) 1.19
Chylous ascites after pancreaticoduodenectomy: introduction of a grading system. J Am Coll Surg (2008) 1.18
Diagnostic accuracy of MRI in differentiating hepatocellular adenoma from focal nodular hyperplasia: prospective study of the additional value of gadoxetate disodium. AJR Am J Roentgenol (2012) 1.17